Pharmafile Logo
Pharmafocus logo
Advanced Search

Japan

Showing 15 posts of 81 posts found.

Working mum develops COVID-19 vaccination database in Tokyo

July 1, 2021
COVID-19, Database, Japan, Vaccine, data

A 36-year-old former English teacher living in Tokyo, Japan, has launched her own healthcare database, Find a Doc, helping non-Japanese …

News
international-2693231_1920

Japan approves Moderna & AstraZeneca COVID-19 vaccines

May 21, 2021
Medical Communications COVID-19, Japan, Vaccine

A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …

News
stock-incyte-01-shutter

Incyte biliary tract cancer treatment approved in Japan

March 23, 2021
Manufacturing and Production EMA, Japan, oncology

The Japanese Ministry of Health, Labour, and Welfare (MHLW) have approved Incyte’s Pemazyre (pemigatinib) for the treatment of patients with …

News

Cabometyx scores Japanese approval for unresectable hepatocellular carcinoma patients following systemic therapy

November 30, 2020
Sales and Marketing Cabometyx, Japan, Takeda

The Japanese Ministry of Health, Labor and Welfare has awarded approval to Takeda for Cabometyx (cabozantinib) as a treatment for …

News

Japan approves Astellas and FibroGen’s Evrenzo for chronic kidney disease patients currently not receiving dialysis

November 27, 2020
Medical Communications, Sales and Marketing Astellas, Japan, fibrogen

Japan’s Ministry of Health, Labour and Welfare (MHLW) has passed approval for Astellas and FibroGen’s Evrenzo (roxadustat) in the treatment …

News
takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …

News
shutter

Japan approves Gilead and Eisai’s Jyseleca for rheumatoid arthritis

September 25, 2020
Medical Communications, Sales and Marketing Eisai, Gilead, Japan, Jyseleca

Gilead and Eisai have secured approval for their oral JAK1 preferential inhibitor Jyseleca (filgotinib) from the Japanese Ministry of Health, …

News

AstraZeneca scores Japanese approval for Imfinzi combo in extensive-stage small cell lung cancer

August 21, 2020
Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, Japan

AstraZeneca’s Imfinzi (durvalumab) has secured approval in Japan for the treatment of extensive-stage small cell lung cancer when combined with etoposide and …

News
shutterstock_2

Japan reserves 120m doses of BioNTech’s COVID-19 vaccine

July 31, 2020
Manufacturing and Production, Medical Communications BioNTech, COVID-19, Japan, Vaccine, pharma

Japan’s Ministry of Health, Labour and Welfare (MHLW) has sealed a deal with Pfizer and BioNTech to secure 120 million …

News

Takeda poised to cut sales jobs in Japan as restructuring continues

July 29, 2020
Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, job cuts

Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new …

News
stock_image_drugs

Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait

July 21, 2020
Manufacturing and Production COVID-19, Fujifilm, Japan, avigan, coronavirus

Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait. The trials will be …

News
japan_mhlw

Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19

May 12, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir

Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …

News
astrazeneca_sign_sky

First for Japan with the approval of AstraZeneca’s Lokelma in hyperkalaemia

March 26, 2020
Sales and Marketing AstraZeneca, Astra|Zeneca, Japan, Lokelma, hyperkalaemia, pharma

Japan’s Ministry of Health, Labour and Welfare has awarded approval to AstraZeneca’s Lokelma for the treatment of hyerkalaemia, marking the …

News
astrazeneca_plaque

Japan grants orphan drug designation to Lynparza for BRCA+ unresectable pancreatic cancer

March 19, 2020
Research and Development, Sales and Marketing AstraZeneca, Japan, lynparza, pharma

AstraZeneca has confirmed that its PARP inhibitor Lynparza (olaparib) has been awarded orphan drug designation in Japan for the maintenance …

News

Japan approves Novartis’ Zolgensma for spinal muscular atrophy in patients under two years old

March 19, 2020
Sales and Marketing Japan, Novartis, Zolgensma, pharma, spinal muscular atrophy

Novartis has revealed that its gene therapy Zolgensma (onasemnogene abeparvovec) has secured approval from Japan’s Ministry of Health, Labour and …

News

Latest content

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024